221 related articles for article (PubMed ID: 22760497)
1. CD24 controls Src/STAT3 activity in human tumors.
Bretz NP; Salnikov AV; Perne C; Keller S; Wang X; Mierke CT; Fogel M; Erbe-Hofmann N; Schlange T; Moldenhauer G; Altevogt P
Cell Mol Life Sci; 2012 Nov; 69(22):3863-79. PubMed ID: 22760497
[TBL] [Abstract][Full Text] [Related]
2. Antibody-based targeting of CD24 enhances antitumor effect of cetuximab via attenuating phosphorylation of Src/STAT3.
Chen Z; Wang T; Tu X; Xie W; He H; Wang M; Zhang J
Biomed Pharmacother; 2017 Jun; 90():427-436. PubMed ID: 28391164
[TBL] [Abstract][Full Text] [Related]
3. CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion.
Baumann P; Thiele W; Cremers N; Muppala S; Krachulec J; Diefenbacher M; Kassel O; Mudduluru G; Allgayer H; Frame M; Sleeman JP
Cell Mol Life Sci; 2012 Feb; 69(3):435-48. PubMed ID: 21710320
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
[TBL] [Abstract][Full Text] [Related]
5. CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.
Bretz N; Noske A; Keller S; Erbe-Hofmann N; Schlange T; Salnikov AV; Moldenhauer G; Kristiansen G; Altevogt P
Clin Exp Metastasis; 2012 Jan; 29(1):27-38. PubMed ID: 21984372
[TBL] [Abstract][Full Text] [Related]
6. Deletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.
Yoshida M; Zhao L; Grigoryan G; Shim H; He P; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(8):G586-98. PubMed ID: 26867566
[TBL] [Abstract][Full Text] [Related]
7. Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas.
Salnikov AV; Bretz NP; Perne C; Hazin J; Keller S; Fogel M; Herr I; Schlange T; Moldenhauer G; Altevogt P
Br J Cancer; 2013 Apr; 108(7):1449-59. PubMed ID: 23511563
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
[TBL] [Abstract][Full Text] [Related]
9. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ
Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216
[TBL] [Abstract][Full Text] [Related]
10. Src and focal adhesion kinase mediate mechanical strain-induced proliferation and ERK1/2 phosphorylation in human H441 pulmonary epithelial cells.
Chaturvedi LS; Marsh HM; Basson MD
Am J Physiol Cell Physiol; 2007 May; 292(5):C1701-13. PubMed ID: 17215324
[TBL] [Abstract][Full Text] [Related]
11. SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.
Hüser L; Sachindra S; Granados K; Federico A; Larribère L; Novak D; Umansky V; Altevogt P; Utikal J
Int J Cancer; 2018 Dec; 143(12):3131-3142. PubMed ID: 29905375
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells.
Pathania D; Kuang Y; Sechi M; Neamati N
Br J Pharmacol; 2015 Jan; 172(1):50-63. PubMed ID: 25047070
[TBL] [Abstract][Full Text] [Related]
13. GDNF induces RET-SRC-HER2-dependent growth in trastuzumab-sensitive but SRC-independent growth in resistant breast tumor cells.
Gardaneh M; Shojaei S; Kaviani A; Behnam B
Breast Cancer Res Treat; 2017 Apr; 162(2):231-241. PubMed ID: 28116540
[TBL] [Abstract][Full Text] [Related]
14. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
Marotta LL; Almendro V; Marusyk A; Shipitsin M; Schemme J; Walker SR; Bloushtain-Qimron N; Kim JJ; Choudhury SA; Maruyama R; Wu Z; Gönen M; Mulvey LA; Bessarabova MO; Huh SJ; Silver SJ; Kim SY; Park SY; Lee HE; Anderson KS; Richardson AL; Nikolskaya T; Nikolsky Y; Liu XS; Root DE; Hahn WC; Frank DA; Polyak K
J Clin Invest; 2011 Jul; 121(7):2723-35. PubMed ID: 21633165
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer.
Byers LA; Sen B; Saigal B; Diao L; Wang J; Nanjundan M; Cascone T; Mills GB; Heymach JV; Johnson FM
Clin Cancer Res; 2009 Nov; 15(22):6852-61. PubMed ID: 19861436
[TBL] [Abstract][Full Text] [Related]
16. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells.
Laird AD; Li G; Moss KG; Blake RA; Broome MA; Cherrington JM; Mendel DB
Mol Cancer Ther; 2003 May; 2(5):461-9. PubMed ID: 12748308
[TBL] [Abstract][Full Text] [Related]
17. Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity.
Kishi T; Mayanagi T; Iwabuchi S; Akasaka T; Sobue K
Oncotarget; 2016 Nov; 7(44):72113-72130. PubMed ID: 27708220
[TBL] [Abstract][Full Text] [Related]
18. SNARE-mediated membrane traffic is required for focal adhesion kinase signaling and Src-regulated focal adhesion turnover.
Skalski M; Sharma N; Williams K; Kruspe A; Coppolino MG
Biochim Biophys Acta; 2011 Jan; 1813(1):148-58. PubMed ID: 20888376
[TBL] [Abstract][Full Text] [Related]
19. Activation of Src and Src-associated signaling pathways in relation to hypoxia in human cancer xenograft models.
Pham NA; Magalhaes JM; Do T; Schwock J; Dhani N; Cao PJ; Hill RP; Hedley DW
Int J Cancer; 2009 Jan; 124(2):280-6. PubMed ID: 18924149
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-3064-5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1/CD24/Src pathway.
Zhang P; Ha M; Li L; Huang X; Liu C
FASEB J; 2020 Jan; 34(1):66-81. PubMed ID: 31914639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
